Dragonfly Therapeutics in $695M cancer R&D pact with Merck

Oct 1, 20182 min read

Merck’s cancer R&D juggernaut ties up to little Dragonfly’s natural born killer platform

Oct 1, 20182 min read

Merck & Co. Partners with Dragonfly on NK-Based Cancer Immunotherapies

Sep 30, 20182 min read

Dragonfly and Merck Strike $695 Million Deal for Solid Tumors

Sep 30, 20182 min read

The Endpoints 11: A group of disruptive upstarts on a do-or-die mission to launch new meds

Jan 10, 20183 min read

Dragonfly Founders to Lead Disruptors Conversation at Boston Biotech

Sep 27, 20171 min read

Celgene bags option on NK cell-based blood cancer assets

Jun 12, 20173 min read

Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal

Jun 12, 20173 min read